Effects of an NO-Synthase Inhibitor L-NMMA in the Hepatopulmonary Syndrome

Publisher： Karger

E-ISSN： 1423-0356|68|2|226-226

ISSN： 0025-7931

Source： Respiration, Vol.68, Iss.2, 2001-03, pp. : 226-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Caffeic Acid Phenethyl Ester (CAPE) on Hepatopulmonary Syndrome

By Tekin Ahmet  

Inflammation, Vol. 34, Iss. 6, 2011-12 ,pp. : 614-619

Springer Publishing Company

Access to resources Recommend Favorite

Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome

By Jounieaux V.   Leleu O.   Mayeux I.  

Intensive Care Medicine, Vol. 27, Iss. 6, 2001-06 ,pp. : 1103-1104

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2547-2555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronological Change in Pulmonary Vascular Response to Hypoxia in Hepatopulmonary Syndrome

By  

Respiration, Vol. 84, Iss. 3, 2012-03 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Proposed Management Algorithm for Severe Hypoxemia After Liver Transplantation in the Hepatopulmonary Syndrome

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 4, 2015-04 ,pp. : 903-913

John Wiley & Sons Inc

Access to resources Recommend Favorite